1. Placenta-Derived Adherent Stromal Cell Therapy for Hematopoietic Disorders
    Noa Sher et al, 2018, Cell Transplant CrossRef
  2. The homing of human umbilical cord-derived mesenchymal stem cells and the subsequent modulation of macrophage polarization in type 2 diabetic mice
    Yaqi Yin et al, 2018, International Immunopharmacology CrossRef
  3. null
    Noa Sher et al, 2018 CrossRef
  4. Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice
    Yaqi Yin et al, 2018, Cell Death Dis CrossRef
  5. Therapeutic Effects of Adipose Stem Cells from Diabetic Mice for the Treatment of Type 2 Diabetes
    Mengmeng Wang et al, 2018, Molecular Therapy CrossRef
  6. Umbilical Cord Blood Banking: Consensus Statement of the Indian Academy of Pediatrics
    Anupam Sachdeva et al, 2018, Indian Pediatr CrossRef
  7. Stem cells in the treatment of diabetes mellitus – focus on mesenchymal stem cells
    Günter Päth et al, 2018, Metabolism CrossRef
  8. Osteogenic Induction of Wharton’s Jelly-Derived Mesenchymal Stem Cell for Bone Regeneration: A Systematic Review
    Ayu Suraya Ansari et al, 2018, Stem Cells International CrossRef
  9. Circular RNAs are abundantly expressed and upregulated during repair of the damaged endometrium by Wharton’s jelly-derived mesenchymal stem cells
    Baolan Sun et al, 2018, Stem Cell Res Ther CrossRef
  10. null
    Youwei Wang, 2019 CrossRef
  11. null
    Y. Cheng et al, 2019 CrossRef
  12. Towards Standardized Stem Cell Therapy in Type 2 Diabetes Mellitus: A Systematic Review
    Mohsen Sheykhhasan, 2019, CSCR CrossRef
  13. Clinicopathological studies on the use of laser-activated adipose-derived stromal vascular fraction in treatment of streptozotocin-induced diabetes in rats
    Safaa Y. Sayed et al, 2019, Comp Clin Pathol CrossRef
  14. Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes
    Yicheng Qi et al, 2019, Stem Cell Res Ther CrossRef
  15. Characteristics and clinical applications of Wharton’s jelly-derived mesenchymal stromal cells
    L.L. Liau et al, 2019, Current Research in Translational Medicine CrossRef
  16. An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy
    Nimshitha Pavathuparambil Abdul Manaph et al, 2019, Stem Cell Res Ther CrossRef
  17. Mesenchymal stem cell therapy in type 2 diabetes mellitus
    Li Zang et al, 2017, Diabetol Metab Syndr CrossRef
  18. Therapeutic potential of mesenchymal stem cells for diabetes
    Alvaro Moreira et al, 2017 CrossRef
  19. Mesenchymal stem cells ameliorate β cell dysfunction of human type 2 diabetic islets by reversing β cell dedifferentiation
    Le Wang et al, 2020, EBioMedicine CrossRef
  20. Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis
    Mary Thompson et al, 2020, EClinicalMedicine CrossRef
  21. Therapeutic Potential of Wharton’s Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges
    Mohamed M. Kamal et al, 2020, Front. Cell Dev. Biol. CrossRef
  22. Small Molecule-Induced Pancreatic β-Like Cell Development: Mechanistic Approaches and Available Strategies
    Gitika Thakur et al, 2020, IJMS CrossRef
  23. Low-Dose Decitabine Assists Human Umbilical Cord-Derived Mesenchymal Stem Cells in Protecting β Cells via the Modulation of the Macrophage Phenotype in Type 2 Diabetic Mice
    Jing Xue et al, 2020, Stem Cells International CrossRef
  24. Identifying the Therapeutic Significance of Mesenchymal Stem Cells
    Vineet Kumar Mishra et al, 2020, Cells CrossRef
  25. Transplantation of human dental pulp stem cells in streptozotocin-induced diabetic rats
    Ahmed Othman Fathy Othman El-Kersh et al, 2020, Anat Sci Int CrossRef
  26. The combined effect of mesenchymal stem cells and resveratrol on type 1 diabetic neuropathy
    Chen Wang et al, 2019, Exp Ther Med CrossRef
  27. VEGF/CDK2 are involved in diabetic organ regeneration
    Rashmi K. Ambasta et al, 2020, Biochemical and Biophysical Research Communications CrossRef
  28. High Dose of Intravenous Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells (CLV-100) Infusion Displays Better Immunomodulatory Effect among Healthy Volunteers: A Phase 1 Clinical Study.
    Sze-Piaw Chin et al, 2020, Stem Cells Int CrossRef
  29. Comparison of similar cells: Mesenchymal stromal cells and fibroblasts
    Burcu Ugurlu et al, 2020, Acta Histochemica CrossRef
  30. Efficacy of mesenchymal stem cell therapy on glucose levels in type 2 diabetes mellitus: A systematic review and meta‐analysis
    Hossein Ranjbaran et al, 2020, J Diabetes Investig CrossRef
  31. Therapeutic efficacy of umbilical cord-derived stem cells for diabetes mellitus: a meta-analysis study
    Dina H. Kassem et al, 2020, Stem Cell Res Ther CrossRef
  32. Diabetes Mellitus Is a Chronic Disease that Can Benefit from Therapy with Induced Pluripotent Stem Cells
    Felipe Arroyave et al, 2020, IJMS CrossRef
  33. null
    Sara M. Ahmed et al, 2020 CrossRef
  34. Therapeutic potential of stem cells from human exfoliated deciduous teeth infusion into patients with type 2 diabetes depends on basal lipid levels and islet function
    Wenwen Li et al, 2021, STEM CELLS Transl Med CrossRef
  35. Quercetin/Zinc complex and stem cells: A new drug therapy to ameliorate glycometabolic control and pulmonary dysfunction in diabetes mellitus: Structural characterization and genetic studies
    Moamen S. Refat et al, 2021, PLoS ONE CrossRef
  36. Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data
    Jingjing He et al, 2021, PLoS ONE CrossRef
  37. Reversion of early- and late-stage β-cell dedifferentiation by human umbilical cord-derived mesenchymal stem cells in type 2 diabetic mice
    Bing Li et al, 2021, Cytotherapy CrossRef
  38. Efficacy of mesenchymal stem cell transplantation therapy for type 1 and type 2 diabetes mellitus: a meta-analysis
    Yanju Li et al, 2021, Stem Cell Res Ther CrossRef
  39. Cytohistologic analyses of β cell dedifferentiation induced by inflammation in human islets
    Rui Liang et al, 2021, Eur J Inflamm CrossRef
  40. Allogenic Use of Human Placenta-Derived Stromal Cells as a Highly Active Subtype of Mesenchymal Stromal Cells for Cell-Based Therapies
    Raphael Gorodetsky et al, 2021, IJMS CrossRef
  41. Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow‐derived mesenchymal stem/stromal cells
    Liem Thanh Nguyen et al, 2021, STEM CELLS Transl Med CrossRef
  42. The Multi-Therapeutic Role of MSCs in Diabetic Nephropathy
    Yi Wang et al, 2021, Front. Endocrinol. CrossRef
  43. null
    Sevim Kahraman et al, 2022 CrossRef
  44. The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice
    Yinzhong Ma et al, 2021, Stem Cell Res Ther CrossRef
  45. The Clinical Efficacy and Safety of Stem Cell Therapy for Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Zhang Yazhen et al, 2020, Aging and disease CrossRef
  46. Impact of Type 2 Diabetes Mellitus on the Immunoregulatory Characteristics of Adipose Tissue-Derived Mesenchymal Stem Cells
    Nourhan Abu-Shahba et al, 2021, The International Journal of Biochemistry & Cell Biology CrossRef
  47. Mesenchymal stromal cell-mediated immune regulation: A promising remedy in the therapy of type 2 diabetes mellitus
    Ji Chen et al, 2021, Stem Cells CrossRef
  48. Human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus: the emerging therapeutic approach
    Andreia Gomes et al, 2021, Cell Tissue Res CrossRef
  49. Diabetes duration and obesity matter in autologous mesenchymal stem/stromal cell transplantation in type 2 diabetes patients
    Joonyub Lee et al, 2021, J of Diabetes Invest CrossRef
  50. HYPERGLYCEMIA REVERSAL IN DIABETIC INFARCTED RAT POSTINTRAVENOUS INFUSION OF HUMAN MESENCHYMAL STEM CELLS
    Sara Jabeen et al, 2021 CrossRef
  51. Safety study of allogeneic mesenchymal stem cell therapy in animal model
    Alvin Man Lung Chan et al, 2022, Regenerative Therapy CrossRef
  52. Mesenchymal Stem Cells (MSCs): A Novel Therapy for Type 2 Diabetes
    Shuang Gao et al, 2022, Stem Cells International CrossRef
  53. Topical and intravenous administration of human umbilical cord mesenchymal stem cells in patients with diabetic foot ulcer and peripheral arterial disease: a phase I pilot study with a 3-year follow-up
    Che Zhang et al, 2022, Stem Cell Res Ther CrossRef
  54. A Comparison of Mesenchymal Stem Cell Lineages for Treatment of Diabetes Mellitus
    Dylan Sadowsky et al, 2022 CrossRef
  55. Effectiveness and safety of human umbilical cord-mesenchymal stem cells for treating type 2 diabetes mellitus
    Xiao-Fen Lian et al, 2022, World J Diabetes CrossRef
  56. Type 2 Diabetes Mellitus and Stem Cell Therapy: A Review
    Tarek W. Wehbe et al, 2017, EMJ Diabet CrossRef
  57. Clinical efficacy of stem-cell therapy on diabetes mellitus: A systematic review and meta-analysis
    Isabella Gouveia Santos Pires et al, 2022, Transplant Immunology CrossRef
  58. The Safety and Efficacy of Mesenchymal Stem Cells in the Treatment of Type 2 Diabetes- A Literature Review
    Aanchal Mathur et al, 2023, DMSO CrossRef
  59. Effectiveness and safety of stem cells in the treatment of diabetes
    S.M. Tkach et al, 2022, Mìžnarodnij endokrinologìčnij žurnal CrossRef
  60. Treatment of type 2 diabetes mellitus with stem cells and antidiabetic drugs: a dualistic and future-focused approach
    Priyamvada Amol Arte et al, 2023, Human Cell CrossRef
  61. Applicability of mesenchymal stem cell-derived exosomes as a cell-free miRNA therapy and epigenetic modifiers for diabetes
    Shikha Sharma et al, 2023, Epigenomics CrossRef
  62. Predictive factors that influence the clinical efficacy of umbilical cord–derived mesenchymal stromal cells in the treatment of type 2 diabetes mellitus
    Yuepeng Wang et al, 2024, Cytotherapy CrossRef
  63. Menstrual Blood–Derived Endometrial Stem Cell Transplantation Improves Male Reproductive Dysfunction in T1D Mice by Enhancing Antioxidative Capacity
    Yilin Lu et al, 2024, Reprod. Sci. CrossRef